Dublin, Jan. 28, 2024 (GLOBE NEWSWIRE) — The “North America Self-Monitoring Blood Glucose Market Size & Share Analysis – Growth Trends & Forecasts (2023 – 2028)” report has been added to ResearchAndMarkets.com’s offering.
The North America Self-monitoring Blood Glucose Market size is expected to grow from USD 7.57 billion in 2023 to USD 10.61 billion by 2028, at a CAGR of 6.98% during the forecast period (2023-2028).
In North America diabetes incidence for type 2 diabetes as well as other diabetes, forms were numerically higher in individuals with Covid-19. Insulin resistance and impaired insulin secretion have been described in individuals without diabetes history who recovered from SARS-CoV-2 infections. It has been suggested that diagnosis and treatment of post-Covid syndrome require integrated rather than disease-specific approaches.
There has been a tremendous increase in the diabetic population worldwide, over the past decade. Several reports and surveys documented a drastic increase in the diabetic population, based on the changes in lifestyles and habits. The growing diabetic population acts as a driver for Blood monitoring devices, such as SMBG. In developed countries, close to 90% of Type-1 diabetic patients use a glucometer. During the forecast period, close to 50% of Type-2 patients are expected to use a glucometer.
North America dominates the global insulin therapeutics market, owing to the high prevalence of diabetes in the region because of the sedentary lifestyle and the launch of new drugs in the region. The United States is expected to grow tremendously during the forecast period, owing to factors, such as the high prevalence of obesity and increasing awareness regarding diabetes care in the region
North America Self-monitoring Blood Glucose Market Trends
Blood Glucose Test Strips Held the Largest Market Share in Current Year
In the current year, blood glucose test strips accounted for about 82% of the North America SMBG market. The Glucometer is a one-time purchase. The Glucometer is a one-time purchase. However, test strips, on the other hand, are a continuous investment, as a test strip needs to be disposed of after one use. However, test strips, on the other hand, arconstantuous investment. Thus, it presents a considerable cost impact to the consumers. Overall, the demand for blood glucose test strips will increase significantly over the forecast period. Development within the market studied is expected to be spurred by the rising diabetic population. While an average glucose meter lasts anywhere between six months and three years, presenting a one-time cost, during the same time frame, the corresponding use of multiple (in the range of thousands) test strips may occur, causing a recurrent cost impact.
The COVID-19 pandemic highlights the need for excellent glycemic management in diabetic patients, partly because most observational studies have found that poorly managed diabetes is related to an increased risk of hospitalization and mortality from a viral disease. Diabetes mellitus has sparked widespread concern due to growing global incidence, resulting in rising cost burdens for health systems, people, and governments. The industry employs different methods such as collaborations, partnerships, mergers, acquisitions, and expansions to expand market share.
The rise in national awareness of diabetes is anticipated to drive the adoption of both SMBGs and CGMs on account of the prognostic and diagnostic treatment of diabetes.
A selection of companies mentioned in this report includes
- Abbott
- F. Hoffmann-La Roche AG
- Platinum Equity (LifeScan)
- Arkray
- Ascensia
- Agamatrix Inc.
- Bionime Corporation
- Acon
- Medisana
- Trivida
- Rossmax
For more information about this report visit https://www.researchandmarkets.com/r/q670mb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- North America Self Blood Glucose Monitoring Market North America Self Monitoring Blood Glucose Market Volume C A G R
